Fidson Healthcare Plc recently praised the pivotal roles of the Bank of Industry (BoI) and the European Investment Bank (EIB) in enhancing Nigeria's pharmaceutical manufacturing sector. This commendation follows a significant visit by EIB delegations, underscoring the international interest in boosting local production capabilities. The BoI has been instrumental in providing concessionary financing, which has enabled companies like Fidson to expand their operations and improve access to essential medicines.
Etop Ekanem, Fidson's Managing Director, stated, "The support from BoI has been crucial in helping us scale our manufacturing processes, ensuring that we meet the growing healthcare demands in Nigeria." This collaboration is particularly vital as Nigeria seeks to reduce its dependence on imported pharmaceuticals and strengthen its domestic industry.
Looking ahead, the partnership between local firms and international financial institutions is expected to foster innovation and increase the country’s competitiveness in the global pharmaceutical market. With continued support, Nigeria may not only enhance its self-sufficiency in healthcare but also position itself as a key player in Africa's pharmaceutical landscape.
